New curative therapy brings hope for the treatment of nodding syndrome
A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.
Jun 4, 2024
0
43
Founded in 1898 by the business community, Liverpool School of Tropical Medicine (LSTM) was the first in the world to conduct on-site research of tropical diseases. Sir Ronald Ross of LSTM was the first British winner of the Nobel Prize for his discovery of the link between mosquitoes and malaria. LTSM scientists are credited for discoveries and treatments of sleeping sickness, elephantiasis, river blindness and recently began monumental work to sequester and treat meningitis and sleeping sickness in Africa. LSTM opened the Centre for Tropical and Infectious Disease in January 2008. CTID is a state-of-the-art research facility in Liverpool which houses a variety of consortiums related to the study of Malaria.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.
Jun 4, 2024
0
43
Researchers from LSTM, in collaboration with researchers in Kenya and the U.S., have been investigating options for girls and young women in low-and-middle-income countries to manage menstruation with comfort and dignity ...
Oct 17, 2023
0
0
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
Mar 13, 2023
0
72
Snakebite envenoming is a priority neglected tropical disease (NTD), and is responsible for around 94,000 deaths each year, mostly in Asia and sub-Saharan Africa. Clinical trials used to test treatments and outcomes in this ...
Jan 31, 2023
0
8
The Ministry of Health in Uganda and partners, including LSTM, are celebrating the elimination of Gambian sleeping sickness following the recent announcement from the World Health Organization (WHO).
Oct 25, 2022
0
20
There remains no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, state the authors of an updated Cochrane Review, which now contains 11 trials across 3,409 people. The authors note ...
Jun 24, 2022
1
39
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, ...
Apr 26, 2022
0
32
The latest update of the Cochrane review "Vaccines for preventing rotavirus diarrhea: vaccines in use" has found that rotavirus vaccines pre-qualified by the World Health Organization (WHO) (Rotarix, RotaTeq, Rotasiil, and ...
Nov 18, 2021
0
2
Research conducted through an equitable partnership of the LSTM and its partners (theRESPOND-Africa consortium), which includes NIMR in Tanzania and MRC/UVRI and LSHTM Uganda Research Unit in Uganda, has found that integrating ...
Sep 10, 2021
0
6
Ivermectin, a drug used to treat parasites such as scabies in humans and intestinal helminths in cattle, was screened in 2020 for activity against COVID-19. Laboratory tests suggested a weak effect on SARS-CoV-2 virus in ...
Jul 28, 2021
0
342